Healthpeak Properties, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Healthpeak Properties, Inc. stock analysis DOC overview
Bullish +75

Healthpeak Properties Gains 22.7% Year to Date: Will the Trend Last?

📈 Healthpeak Properties (DOC) shares have gained 22.7% year-to-date, significantly outperforming the industry's 12.7% upside.

⚖️ The stock carries a Zacks Rank #3 (Hold), while management is strategically positioning toward lab, outpatient medical, and life plan assets in high-barrier markets.

🏥 Strong leasing momentum and rising occupancy are driving growth, particularly within the senior housing platform known as Janus Living.

🧪 In the lab segment, Healthpeak executed 141,000 square feet of leases in Q1 2026 with total occupancy reaching 77.7%.

🏥 The outpatient medical segment achieved nearly 1.1 million square feet of leases and maintained 91% total occupancy as of Q1 2026.

👴 Janus Living reported a 35% year-over-year revenue growth and a 42% expansion in adjusted EBITDA for the first quarter of 2026.

💰 The company generated $267 million in proceeds from recapitalizations and dispositions to fund focused growth while enhancing liquidity.

📉 Net debt-to-EBITDA stood at 5.4x at the end of Q1 2026, with cash and equivalents rising to $1.17 billion following Janus Living IPO proceeds.

🏦 Healthpeak maintains long-term credit ratings of Baa1 from Moody's and BBB+ from S&P Global as of May 4, 2026.

📉 The company increased financial flexibility by adding a new $400 million unsecured delayed-draw term loan.

⚠️ Risks include competition from other healthcare services players, rising construction costs, and the substantial debt burden.

🔍 Management expects year-end 2026 lab occupancy to be higher than the 2025 level despite current market conditions.

📈 The outpatient segment achieved 5.4% cash re-leasing spreads on renewals with a robust pipeline under letter of intent (LOI).

🏢 Healthpeak continues to use structured transactions to maintain investment flexibility across different economic cycles.

📊 FFO is the primary metric used to gauge performance for this REIT, as noted in the financial analysis section.

Bullish Signals
  • Shares of Healthpeak Properties (DOC) have gained 22.7% year-to-date, significantly outperforming the industry's upside of 12.7%.
  • The company is strategically positioning toward lab, outpatient medical, and life plan assets in high-barrier markets driven by strong leasing momentum and rising occupancy.
  • In the first quarter of 2026, Healthpeak executed 141,000 square feet of lab leases with 92% tied to new leasing, pushing total lab occupancy to 77.7%.
  • Management expects year-end 2026 lab occupancy to be higher than the 2025 level, indicating continued growth potential in this segment.
  • The outpatient medical segment achieved 5.4% cash re-leasing spreads on renewals and ended the quarter at 91% total occupancy with 79% tenant retention.
  • Healthpeak's senior housing platform, Janus Living, reported year-over-year revenue growth of 35% and adjusted EBITDA expansion of 42% for the first quarter of 2026.
  • Senior housing same-store cash net operating income (NOI) grew 13.8% year over year in the first quarter of 2026, reflecting stronger operating performance.
  • The company generated $267 million of proceeds from recapitalizations, dispositions, and loan repayments in the first quarter of 2026 to fund focused growth.
  • Cash and cash equivalents rose to $1.17 billion from $467.5 million in the last quarter following Janus Living IPO proceeds, bolstering near-term liquidity.
  • Healthpeak maintained strong long-term credit ratings of Baa1 from Moody's and BBB+ from S&P Global as of May 4, 2026.
Risk Factors
  • Competition from other industry players in the healthcare services sector is explicitly identified as a key concern for Healthpeak.
  • The article states that substantial debt burden adds to the company's woes.
Full Analysis
Healthpeak Properties (DOC) shares have gained 22.7% year-to-date, outperforming the healthcare real estate industry's 12.7% gain as of May 26, 2026. The company is strategically focusing on lab, outpatient medical, and life plan assets in high-barrier markets like San Diego, San Francisco, and Boston, supported by strong leasing momentum and rising occupancy rates. In the first quarter of 2026, Healthpeak executed 141,000 square feet of lab leases with 92% tied to new leasing, bringing total lab occupancy to 77.7%, up from 77% at year-end 2025. Management expects year-end 2026 lab occupancy to exceed 2025 levels. The outpatient medical segment also shows steady fundamentals with nearly 1.1 million square feet of leases executed in Q1 2026, achieving a 5.4% cash re-leasing spread on renewals and ending the quarter at 91% total occupancy with 79% tenant retention. The company's senior housing platform, Janus Living, reported year-over-year revenue growth of 35% and adjusted EBITDA expansion of 42% for the quarter, with same-store cash net operating income growing 13.8%. Healthpeak generated $267 million in proceeds from recapitalizations, dispositions, and loan repayments in Q1 2026 to fund growth while maintaining liquidity, ending the quarter with $1.17 billion in cash and a net debt-to-EBITDA ratio of 5.4x. The company also secured a new $400 million unsecured delayed-draw term loan to enhance financial flexibility.